Clinical Trial Update: The Role of IL-23-Responsive Immune Cell Subsets in Post-Operative Recurrence in Patients With Crohn's Disease.

View source ↗

Summary

A clinical trial update exploring the role of IL-23-responsive immune cell subsets in postoperative recurrence of Crohn's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Crohn´s Disease | Status: RECRUITING